Cadila Healthcare submits press release

05 Dec 2019 Evaluate

Cadila Healthcare has informed about submission of a copy of press release dated December 5, 2019 titled ‘Zydus announces regulatory filing of Saroglitazar Magnesium for treatment of NASH with DCGI’. The contents of the press release give full details. 

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

882.00 14.20 (1.64%)
19-Jan-2026 15:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.25
Dr. Reddys Lab 1165.85
Cipla 1391.40
Zydus Lifesciences 882.00
Lupin 2178.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×